Bio-Rad Laboratories (BIO) EBT Margin (2009 - 2026)
Bio-Rad Laboratories (BIO) posted quarterly EBT Margin of 116.5% for Q1 2026, down 13075.0% year-over-year from N/an in Q1 2025, and down 186.91% quarter-over-quarter from 134.05% in Q4 2025.
Bio-Rad Laboratories (BIO) EBT Margin (2009 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported EBT Margin for 18 consecutive years, with 116.5% the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT Margin fell 13075.0% year-over-year to 116.5%; the TTM figure through Mar 2026 stood at 8.58% (up 11681.0% YoY), while the FY2025 annual figure was 38.54%, up 12981.0% from the prior year.
- EBT Margin fell to 116.5% in Q1 2026 per BIO's latest filing, from 134.05% in the prior quarter.
- Across five years, EBT Margin topped out at 149.45% in Q4 2022 and bottomed at 623.92% in Q1 2022.
- Historically, EBT Margin has averaged 66.76% across 5 years, with a median of 12.53% in 2023.
- Annual changes were most pronounced in 2022 — EBT Margin plunged 80240 bps — and 2023, when it soared 63645 bps.
- Bio-Rad Laboratories' EBT Margin stood at 149.45% in 2022, then slumped by 58 bps to 62.89% in 2023, then slumped by 317 bps to 136.16% in 2024, then surged by 198 bps to 134.05% in 2025, then sank by 187 bps to 116.5% in 2026.
- Business Quant data shows BIO's EBT Margin at 116.5% in Q1 2026, 134.05% in Q4 2025, and 66.02% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | 12.10% |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 23.74% |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 19.48% |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 29.86% |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 24.27% |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 13.09% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | 8.91% |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 18.32% |
| 10 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | 83.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 83.27% |
| Mar 31, 2026 | -116.50% |
| Dec 31, 2025 | 134.05% |
| Sep 30, 2025 | -66.02% |
| Jun 30, 2025 | 63.54% |
| Mar 31, 2025 | 14.25% |
| Dec 31, 2024 | -136.16% |
| Sep 30, 2024 | 132.62% |
| Jun 30, 2024 | -436.38% |
| Mar 31, 2024 | 80.40% |
| Dec 31, 2023 | 62.89% |
| Sep 30, 2023 | 21.69% |
| Jun 30, 2023 | -220.29% |
| Mar 31, 2023 | 12.53% |
| Dec 31, 2022 | 149.45% |
| Sep 30, 2022 | -30.45% |
| Jun 30, 2022 | -176.56% |
| Mar 31, 2022 | -623.92% |
| Dec 31, 2021 | -276.62% |
| Sep 30, 2021 | 672.32% |